AG NPP709 is currently available on the market; nonetheless, no examine has investigated the impact of AG NPP709 in patients with COPD. Consequently, the aim of this review was To judge the efficacy of AG NPP709 in clients with Continual bronchitis variety COPD.Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor necrosis el